Aether Biomachines
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- $75M
Investors
- 9
About Aether Biomachines
Aether Biomachines, Inc. is a US-based company specializing in advanced enzyme engineering, utilizing a proprietary platform for creating innovative biocatalysts that enhance manufacturing processes across various industries. Founded in 2017 in Menlo Park, US, Aether Biomachines, Inc. Aether Bio specializes in advanced enzyme engineering, employing a proprietary platform that allows for the rapid and efficient creation of biocatalysts. Their offerings include custom-designed enzymes, which facilitate the production of complex and novel products at significantly reduced costs. By mapping trillions of enzymes, Aether provides a searchable index for clients in sectors such as pharmaceuticals, biofuels, and specialty chemicals, addressing challenges in scalability and efficiency. Their global client base spans North America, Europe, and Asia. Aether Bio generates revenue primarily through strategic partnerships and direct business-to-business transactions, providing custom enzyme design services. Clients engage Aether to develop specific biocatalysts tailored to their needs, with pricing based on project agreements or retainers for ongoing support. Revenue structures are determined by the complexity of the enzyme engineering required. In December 2025, Aether Biomachines, Inc.
Who invested in Aether Biomachines
9 investors across 3 rounds
See all investors in Aether Biomachines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aether Biomachines
Who invested in Aether Biomachines?
Aether Biomachines has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aether Biomachines raised?
Aether Biomachines has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Aether Biomachines last raise money?
Aether Biomachines's most recent round on record is a Series A, in Dec 2025.
What does Aether Biomachines do?
Aether Biomachines is a biotechnology company.
Where is Aether Biomachines headquartered?
Aether Biomachines is headquartered in Menlo Park, US.
Which VCs invest in companies like Aether Biomachines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aether Biomachines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Aether Biomachines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.